Norwich Pharmaceuticals is a manufacturer, packager and distributor of prescription drugs and over-the-counter products. Laboratory support services include stability evaluation, microbiological testing, analytical testing and method development. The company was formed in 1887.[1][2][3][4][5][6]
The Norwich Pharmaceutical Company was established in Norwich, New York in 1887. In 1893, Norwich introduced Unguentine to the medical profession as the first antiseptic surgical dressing. The company’s mixture called Cholera Infantum, later renamed Pepto-Bismol, appeared for the first time in 1901. Its principal use was for infants with severe diarrhea. In 1907, Acetylsalicylic acid (aspirin) tablets were added to the company’s product line. In 1939, Norwich Pharmaceutical stock was listed on the New York Stock Exchange. During World War II, the company earned the Army-Navy ‘E’ Award with four added stars in recognition of its support of the troops and war effort. In 1982, the company, then called Norwich Eaton Pharmaceuticals, became a wholly owned subsidiary of the Procter & Gamble Company. In the mid 1990s, Norwich constructed an Intermediate Potency solid dose form facility, from which the osteoporosis drug Actonel was launched. The Norwich, NY, plant was purchased from Procter & Gamble Pharmaceuticals in 2001 and transitioned into its current role as an outsourcing provider to the pharmaceutical industry. A long-term contract was signed with Procter & Gamble, which remains in force today.